Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4088/PCC.23cr03694 | DOI Listing |
Prim Care Companion CNS Disord
May 2024
Texas Tech University Health Sciences Center at Permian Basin, Lubbock, Texas.
Pharmacology
June 2015
School and Division of Allergology and Clinical Immunology, University of Messina, Messina, Italy.
Background: Montelukast, a leucotriene receptor antagonist, binds the cysteinyl leucotriene type 1 receptor. Montelukast is commonly prescribed to asthma patients as add-on therapy to inhaled corticosteroids. Several clinical trials emphasized that montelukast can be considered a safe drug.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!